The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
A national, non-profit, public charity, the Caring Ambassadors Hepatitis C Program makes it easier for people with Hepatitis C to learn about the virus, its implications and up-to-date treatments. By utilizing the internet, people can get a customized response to their specific Hepatitis C concerns.
Continue reading »According to new research from Sweden, grabbing a quick burger and fries is just as harmful to the liver as drinking alcohol. Since liver damage carries a graver risk to those living with Hepatitis C, eating low-fat meals is more important to this population than ever.
Continue reading »Michigan researchers have found that a new combination of markers may best predict the progression of cirrhosis for people with chronic Hepatitis C. Although requiring additional study for confirmation, these three serum fibrosis markers demonstrated a higher level of accuracy than other non-invasive tests
Continue reading »People treated at a Nevada Health Center may have been infected with Hepatitis C from an unsafe medical procedure. Thousands of people are being notified that they may have been exposed to this and other blood-borne viruses from the re-use of contaminated anesthesia equipment.
Continue reading »Even though there are more reasons than ever for those with chronic Hepatitis C to have a daily glass of grapefruit juice, there is a catch. Unfortunately, there is a long list of medications that can be dangerous when combined with this fruit.
Continue reading »Two big pharmaceutical companies, Schering-Plough and OraSure, have agreed to work together to deliver a rapid, oral Hepatitis C test. In addition to their collaboration within the United States, this new agreement focuses on bringing this technology to additional markets.
Continue reading »Massachusetts researchers have found that a compound in grapefruit blocks the Hepatitis C virus from infecting additional cells. Since the Hepatitis C virus depends on cholesterol metabolism to proliferate, future trials may prove that lipid-lowering drugs or supplements, such as that found in grapefruit, may inhibit the virus.
Continue reading »A new study from Bulgaria proves that Hepatitis C infection is not only a liver disease, but affects many different parts of the body. Their research demonstrates that over three quarters of people with Hepatitis C have extra-hepatic manifestations and it helps physicians identify who is at the greatest risk.
Continue reading »Indicating patient preference for PegIntron™, Schering-Plough recently publicized their Hepatitis C trial, "IDEAL." However, competitor Roche indicates several IDEAL trial design issues that make for a poor comparison to their PEGASYS® with COPEGUS®.
Continue reading »After following participants for one year, a large Japanese study concludes that treating Hepatitis C aggressively reduces the occurrence of non-Hodgkin's lymphoma.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
